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Summary
Background: People with substance use disorders frequently present life stories marked by suffering and loss. Few 
studies have assessed the role of bereavement of a significant person in the drug dependent population. Aim: This study 
explored the loss of a significant person among 196 bereaved drug dependent patients before and after the age when they 
consider that their drug consumption increased. Methods: Socio-demographic characteristics, bereavement and drug 
related variables were examined. Perceived relationship between the significant loss and drug consumption was also as-
sessed. Complicated grief symptomatology was measured by the Spanish version of the Inventory of Complicated Grief 
(ICG). Results: 83.2% of all participants stated that, after suffering the loss, they increased drug consumption. 12.3% of 
the patients who first increased drug consumption and after suffered the loss of a significant person reported a relapse after 
the loss. However, 54% of the participants who first experienced the loss and after increased their drug consumption did 
not perceive any relationship between the loss and their own drug consumption. The most frequent losses were the parents 
(father and mother), sibling being the third most significant loss. 34.2% of patients reported symptoms of complicated 
grief. Conclusions: Results show a relationship between the loss and the important increase of substance consumption. 
This study suggests the importance of including the process of grief psychotherapy within the treatment of drug dishabitu-
ation for those cases which presented symptoms of complicated grief.
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1. Introduction
Addiction is a mental health problem implicat-
ing issues at different levels, such as traumatic expe-
riences during childhood [10], economic instability, 
unemployment [34], marital problems, accidents [23, 
24], social exclusion [3, 9], physical complications, 
as well as medical difficulties and high psychiatric 
comorbidity [1, 30]. These biopsychosocial factors 
could raise the vulnerability and even exacerbate the 
prognosis of the addiction. Substance abusers and the 
drug dependent population frequently present life sto-
ries marked by suffering and loss [29]. The loss of 
a significant person due to death is one of the most 
stressful life-events [16, 17, 29]. Although the vast 
majority of people are able to manage the loss, a con-
siderable minority is predisposed to express persis-
tent and disabling symptoms [20, 36]. Complicated 
grief (CG) has been defined as a deviation from the 
normal (in cultural and societal terms) grief experi-
ence in either time course, intensity, or both, entail-
ing a chronic and more intense emotional experience 
or an inhibited response, which either lacks the usual 
symptoms or in which onset of symptoms is delayed 
[33].
Accordingly, different studies have reported 
a link between losing a significant person and drug 
consumption among substance users [2, 11, 21, 38]. 
Some researches show an incidence of early loss of at 
least one of the parents among addicted patients [8, 
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15, 37]. In this regard, a study from the comparison 
between heroin consumers and non-consumers, ob-
served that one of the main differences between the 
two groups is that heroin users have experienced the 
loss of one of their parents before the age of 16 [14]. 
In another study, half of opioid-dependent patients 
and 40% of cocaine-dependent patients experienced 
the loss of both parents before the age of 21 [12]. 
Furthermore, different authors based on a descriptive 
study reporting family characteristics of drug-related 
deaths examined at the Viennese Institute of Forensic 
Medicine, stated that 80% of addicted patients have 
experienced at least one traumatic event during their 
childhood, such as the loss of a parent [27]. Like-
wise, several authors have noted the possible rela-
tionship between loss of a significant other and drug 
consumption among substance dependence [13, 21, 
38]. In the same view, 20% of individuals diagnosed 
with an alcohol dependence disorder start drinking 
alcohol after a loss [6]. After studying the reasons 
for relapse in 270 heroin addicts, users who have ex-
perienced stressful life events, such as a recent loss, 
show greater difficulty in adapting to a new lifestyle 
without drugs [18]. According to the study, almost 
half of the respondents (48%) used heroin as an adap-
tive attempt to regulate and control high anxiety and 
at the same time as a way of managing stressful life 
events. The link between bereavement and alcohol 
problems was corroborated among a sample of a be-
reaved 4457 patients who had lost a close relative in 
the past three years [25]. In the same vein, 93.9% of 
after the dependence age of onset reported the death 
of a close friend or relative among 82 heroin-depend-
ent patients. According to these authors, the addiction 
might be affected by traumatic life events but it also 
impacts their development [29]. Life events in drug-
dependent people can prompt the initial contact with 
the substance but at the same time, it could also affect 
the course of the disease by intensifying craving [32]. 
Taking into account these studies, it is important 
to establish the relationship between the loss of a sig-
nificant one and drug consumption among bereaved 
people diagnosed with substance use disorder in order 
to address this issue in treatment. However, the above 
studies have not paid close attention to the course 
over time of bereavement experiences in relationship 
to changes in drug consumption. For that reason, the 
current study aims to shed light on the differences in 
bereavement, addiction, as well as sociodemographic 
variables, between persons who first lost a significant 
person and afterwards increased drug consumption 
(“B-A”), and those individuals who started using 




The participants in this study were patients re-
ceiving treatment at the Public Addiction Treatment 
Centre in Girona (Catalonia, Spain). The sample con-
sisted of 196 adults (78.1% male). The inclusion cri-
teria were 1) they had a diagnosis of alcohol, cocaine 
or heroin dependence carried out by clinical special-
ists in the centre according to DSM-IV-TR criteria, 
2) they suffered a loss of a significant person (family, 
best friend or partner) at some time in their life, but 
at least a year previously to the interview, and any 
bereavement within the year previous to the interview 
would exclude them from this study and 3) abstinence 
during the last month to avoid toxic effect of drugs. 
This study is part of a wider investigation based 
on symptomatology of CG among drug dependent 
people. For this reason, the sample size was calcu-
lated based on the estimated prevalence of CG in the 
general population and an assumed prevalence of 
15%, with an alpha level of 0.05 for a precision of ± 
0.05. In order to retain the required number of par-
ticipants, we had to interview 205 patients because 9 
cases were rejected for not fulfilling the criteria. 
We divided the sample into two groups (“B-A” 
and “A-B”) in order to assess the possible effect of 
bereavement on drug consumption. These categories 
were made from the difference between how old the 
patient was when the significant person died and at 
what age the patient recalled that they increased the 
frequency of consumption of primary drug. Partici-
pants classified in “B-A” (preaddiction bereavement) 
had a significant loss (at an average of 21 years, SD= 
10.7) before the age in which they increased the con-
sumption of drugs (M=30.8; SD=11.02). Hence, they 
suffered a bereavement process before increasing 
drug consumption. The average age of onset of the 
drug consumption was 18.5 years (SD=8.7). Patients 
who first increased drug consumption (M=22.23; 
SD=8.40) and after suffered the loss of a significant 
person (at 37.9 years and SD= 10.53) were grouped 
in “A-B” (post addiction bereavement). The average 
age of onset of drug consumption was 15.62 (SD= 
5.28). Most of the participants were categorised in the 
second one “A-B” (74.9%).
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2.2. Instruments
We used a self-constructed questionnaire to 
measure sociodemographic variables, drug use-relat-
ed variables as well as bereavement-related charac-
teristics.
Several sociodemographic characteristics were 
assessed: age, gender, marital status (single, married 
or with partner, separated or divorced, widowed), 
education (primary or college education), and work 
status (working, or retired, unemployed, or on dis-
ability aid).
The drug use-related variables determined were: 
main drug dependence (alcohol, cocaine or heroin), 
age at onset of, and age at increase in the consump-
tion of the drug (determined by the question of how 
old the patient was when he/she first increased con-
sumption of the main drug). The participant was 
asked if she/he took prescribed pills. The perceived 
relationship between the death of a significant person 
and drug consumption was also inquired into (the re-
lationship was determined by asking if the participant 
considered that there was a relationship between the 
loss and that person’s main substance consumption). 
Bereavement-related variables asked about 
were: the most significant/closest loss experience, 
time since death (in years), what age the participant 
was when they had lost the significant person, and 
circumstances of death (natural or illness-related and 
traumatic). Level of current of the significant loss was 
reported on a subjective 10-point Likert scale (0–no 
effect to 10–maximum level of effect exerted by the 
loss as evaluated at the moment of the interview). 
Complicated grief was assessed using the Span-
ish version of the Inventory of Complicated Grief 
(ICG) [17]. It comprises 19 items. Responses are pro-
vided on a 5-point Likert scale to assess an increase 
in severity (0–never, 1–seldom, 2–sometimes, 3–of-
ten and 4–always) (maximum score: 76). The cut-off 
point was 25, and it was based on the English version 
of the ICG [24].  We categorized a respondent as hav-
ing symptoms of CG if the total score was higher than 
25. The internal consistency of the Spanish version 
was high (Cronbach’s alpha = .88; test-retest reliabil-
ity = .81).
2.3. Procedure
Participants who met the three inclusion criteria 
were informed by their therapist about possible par-
ticipation in the study. If patients agreed to collabo-
rate, the psychologist (who is the first author) called 
each patient to arrange an appropriate time for an in-
terview in the centre. All participants were informed 
about the study procedure as well as terms of confi-
dentiality. The average time for each interview was 
one hour and a half in total. Informed consent was 
obtained from all participants and the protocol was 
approved by the Institutional Ethics and Research 
Review Board of Institut Assistència Sanitària (IAS). 
2.4. Statistical Analyses
In order to compare “B-A” group and “A-B” 
group we used chi-square tests, to identify relation-
ships between the categorical variables (applying the 
Yates correction when necessary) and the Student’s 
t-tests, to determine the relationship between the 
quantitative and the qualitative variables. The results 
are expressed as absolute numbers, percentages, as 
well as showing the means and standard deviations. 
The categorization of questions about the relation-
ship between the loss and the drug itself was based on 
five possible answers (No; Yes, increase; Yes, relapse; 
Yes, abstemious and Yes, initiation). A statistical sig-
nificance of 0.05 was set for testing the hypotheses. 
All analysis were conducted with the Statistical Pack-
age for the Social Sciences (SPSS 21.0) for Windows.
3. Results
3.1. Sociodemographic characteristics 
Gender proportions were different between the 
groups. There were more women in the “B-A” group 
(pre-addiction bereavement). Almost half of the B-A 
participants were married or with a partner and 10.3% 
of “A-B” participants were widowed. 
Related to the level of education, more “B-A” 
participants stated of having secondary-level educa-
tion, compared to the “A-B” group. The majority of 
participants had no working status which means that 
they were either unemployed, retired or with disabil-
ity aid (Table 1).
3.2. Drug-related characteristics 
As Table 2 shows, the first main diagnosis was 
alcohol dependence. One difference between the 
groups is that the secondary main diagnosis was 22% 
having cocaine dependence in “B-A” group, whereas 
in the “A-B” group the secondary main diagnosis 
was heroin dependence (19.9%). The relationship be-
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tween prescribed medicine and “B-A” and “A-B” was 
statistically significant (p=.019). More than a half of 
the individuals of “A-B” reported taking prescribed 
pills.
In Table 3 the subjective answer of the partici-
pants relating to whether they consider that any re-
lationship exists between the loss of the significant 
person and their own drug consumption is displayed. 
There was a statistically significant difference: In the 
“B-A” group almost half of the individuals consid-
ered that there was no of relation between the loss and 
their consumption of drugs, while a significantly larg-
er proportion - 66.4% - of the participants in the “A-
B” reported a significant relationship. In this regard, 
the loss negatively affected their drug consumption, 
with 45.2% increasing their consumption and 12.3 
suffering a relapse after the loss. However, it should 
be noted that 8.9% of individuals of “A-B” reported 
being abstemious after the loss.
3.3. Bereavement characteristics
Almost half of the “B-A” individuals lost their 
father (44%), 16% lost their mother and 16% their 
sibling. Of the “A-B” participants, 30.8% lost their fa-
ther, 19.9% lost their mother and 19.2% their sibling. 
With regard to circumstances of death, the majority 
of respondents in both groups reported natural cir-
cumstances. The mean time since the death of the sig-
nificant person was 21.60 years for the “B-A” group 
and 8.42 years for the “A-B” group (Table 3). Partici-
pants also reported their level of upset on losing the 
significant person (M=6,83; SD=3.06). There was a 
significant difference (p=.007) between “B-A” group 
Table 1. Sociodemographic characteristics of the bereaved sample
  B-A (n=50) A-B (n=146) p
Age, M (SD) 43.32 (9.86) 46.35 (10.15) 0.06a
Gender, N (%) 0.046b
 Man 34 (68) 119 (81.5)
  Woman 16 (32) 27 (18.5)
Marital status, N (%) 0.184b
 Single 9 (18) 35 (24)
 Married/Partner 21 (42) 52 (35.6)
 Separated/Divorced 19 (38) 44 (30.1)
 Widowed 1 (2) 15 (10.3)
Education, N (%) 0.179b
 Primary 10 (20.4) 49 (34.5)
 Secondary 38 (79.6) 90 (65.5)
Working situation, N (%)
 Work 19 (38) 53 (36.3) 0.830b
 Others* 31 (62) 93 (63.7)
* Retired, unemployed, inactive, on invalidity benefit; a t-test test; b chi-square test
Table 2. Addiction variables of the participants.
B-A (n=50) A-B (n=146) P
Main diagnosis, N (%)   0.066a
Alcohol 32 (64) 103 (70.5)
Cocaine 11 (22) 14 (9.6)
Heroin 7 (14) 29 (19.9)
Age increment, M (SD) 30.82 (11.2) 22.23 (8.40) <0.001b
Prescribed medication, N (%) 0.019a
Yes 31 (62) 115 (78.8)
No 19 (38) 31 (21.2)
a chi-square test; b t-test test.
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occurred after their addiction had begun. The larger 
group was the “A-B” group (74.9%). These persons, 
reported an earlier occurrence of the increase of drug 
consumption and higher symptomatology of CG than 
“B-A”. 39% of the “A-B” group showed symptoms of 
CG, which means that almost four out of ten of those 
patients who were in treatment and experienced a 
death of somebody significant, presented symptoma-
tology of CG. In both groups the most frequent loss 
was the father which was the same in line with other 
studies [27]. Related to gender issue, more women 
were in the “B-A” group which indicate an earlier be-
reavement. In this regard, several studies underlined 
differences between women and men [31, 35]. 
Turning to the perceived relationship between 
loss and their own drug consumption, 54% of “B-A” 
participants did not perceive any relationship between 
(M=5.81; SD=3.47) and “A-B” group (M=7.17; 
SD=2.83). The “A-B” group reported a higher level 
of suffering related to the death at the time of the 
interview. Similarly, the symptoms of CG were sig-
nificantly different between the groups (p=.021). The 
“A-B” participants reported higher scores in the CG 
test (M= 24; S.D.= 17.12) than the “B-A” individuals 
(M= 15.26; S.D= 13.54). 39% of the “A-B” patients 
reported CG-level of symptomatology.
4. Discussion
The current study aimed to increase knowledge 
about relationships between bereavement, addiction, 
and sociodemographic variables among persons who 
suffered bereavement before becoming addicted, 
compared with those whose bereavement experience 
Table 3. Perceived relationship between the significant loss and drug consumption.  (n (%))
  B-A (n=50) A-B (n=146) p
No 27 (54)    49 (33.6) <0.001
Yes, increase 19 (38)    66 (45.2)
Yes, relapse 0 (0)    18 (12.3)
Yes, abstemious 0 (0)    13 (8.9)
Yes, initiation 4 (8)    0 (0)  
Table 4. Bereavement characteristics of the participants.
  B-A (n=50) A-B (n=146) p
Relationship profile of deceased, n (%) 0.062a
   Father 22 (44) 45 (30.8)
   Mother 8 (16) 29 (19.9)
   Sibling 8 (16) 28 (19.2)
   Grandparent 6 (12) 5 (3.4)
   Spouse 1 (2) 18 (12.3)
   Friend 3 (6) 11 (7.5)
   Others 2 (6) 10 (19.1)
Circumstances, n (%) 0.880a
   Natural 36 (72) 106 (73.1)
   Traumatic*0 14 (28) 39 (26.9)
Time since loss┼, M (SD) 22.32 (12.51) 8.42 (7.89) <0.001b
Age patient±, M (SD) 21 (10.73) 37.92 (10.52) <0.001b
Symptoms of CG, n (%) 0.014a
   Yes 10 (20) 57 (39)
   No 40 (80) 89 (61)  
Symptoms of CG, M (SD) 15.64 (13.74) 23.82 (17.18) 0.001b
a chi-square test; b t-test test. * Traumatic: accident, suicide, homicide and overdose; ┼ time since loss in years;  ± age of the parti-
cipant when the lost happened.
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appears to be an "obstructive" factor to abstinence, 
and also the need for adaptive coping strategies and 
tools for recovery.
Limitations
This study had a number of limitations. We re-
lied exclusively on self-report measures. The age of 
onset of increased drug consumption as well as the 
age when the participant lost the significant person 
was based on retrospective recall. Moreover, it was 
difficult to ensure abstinence, especially from second-
ary addictions such as tobacco or cannabis, of partici-
pants. The present research had a cross-sectional de-
sign, with no control group, hence causal inferences 
cannot be made. 
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